PCSK9 and homozygous familial hypercholesterolemia: However, most patients with HoFH and fewer patients with refractory HeFH, including those taking a maximally tolerated high-intensity statin, an ezetimibe, and a PCSK9 inhibitor, have persistent elevations in LDL-cholesterol requiring the use of expensive and poorly tolerated medications or apheresis procedures.